Flora Growth (NASDAQ:FLGC) Releases Quarterly Earnings Results, Misses Expectations By $0.31 EPS

Flora Growth (NASDAQ:FLGC) announced its quarterly earnings results on Monday. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.31), Zacks reports. Flora Growth had a negative net margin of 30.99% and a negative return on equity of 268.17%. The business had revenue of $13.33 million for the quarter, compared to analysts’ expectations of $13.55 million.

Flora Growth Price Performance

Flora Growth stock opened at $0.67 on Wednesday. Flora Growth has a one year low of $0.59 and a one year high of $2.93. The company has a quick ratio of 0.64, a current ratio of 1.02 and a debt-to-equity ratio of 0.43. The business has a fifty day moving average price of $0.80 and a 200-day moving average price of $1.17.

Flora Growth Company Profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.